Pfizer Reports Positive Phase 2 Results for Atopic Dermatitis Drug

3-line summary

• Pfizer reported positive phase 2 results for its atopic dermatitis drug, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.